|Changing therapy from Trizivir
Nov 9, 2005
Dear Doctor Henry Following your comments of 8th November I am now changing from Trivizir to Viramune, Epivir and Viread. The exact combos. you mentioned are not yet available here in France. My T cell count is stable at 450. At a first glance is this a suitable combination as a second go at therapy ? I am concerned about the liver as I have had hepatitis A , B and C and still remain antibody positive for these liver conditions although have not had a problem for 25 years with the liver. Would you second this choice that has been made for me or would you go for something else - I do not want to change meds. after this - I want to get this right ! I have to start taking the new combo. this week and so if you have time to respond now I can go ahead with taking them with some confidence. Many thanks, George
| Response from Dr. Henry
Most patients would do OK changing to the regimen you outlined though liver status needs to be monitored carefully. Efavirenz is an alternative to the nevirapine as would be number of ritonavir boosted or non-boosted protease inhibitors. Good luck.
Get Email Notifications When This Forum Updates or Subscribe With RSS
- Oral Ulcers After Touching Precum Sign Of HIV AIDS
- Pain In Balls After Barebacking Sign Of HIV AIDS
- Painful Ejaculation After Anal Sex Without Condom Does It Mean I Have HIV
- Tingling In Fingers After Getting A Tattoo Worried I Have HIV
- Can A Vaginal Cyst Cause Swollen Lymph Nodes?
- Can Hpv Cause Pain?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.